Solution :
Cash flow
Statement- Ayayi Corp's For year ended December 31, 20Y3 |
||
Particulars | Details | Amount |
Cash Flow from Operating Activities: | ||
Net Income ($1,310,850 -
$1,196,190 + $24,190) Closing retained earnings + Opening Retained Earnings - Proposed Dividend |
$138,850.00 | |
Adjustments to reconcile net income to cash flow from operating activities: | ||
Depreciation | $18,470.00 | |
Gain on sale of investment ($279,190 - $240,620) | -$38,570.00 | |
Increase in Accounts Receivables ($228,100 - $208,850) | -$19,250.00 | |
Increase in Invetory ($640,910 - $617,650) | -$23,260.00 | |
Increase in Accounts Payable ($425,280 - $404,550) | $20,730.00 | |
Decrease in accured expenses payable ($52,020 - $41,990) | -$10,030.00 | |
Total Adjustments | -$51,910.00 | |
Net Cash Flow From Operating Activites (A) | $86,940.00 | |
Cash Flow from Investing Activities: | ||
Cash proceed from sale of investment | $279,190.00 | |
Cash paid for purchase of equipment ($704,540 - $553,320) | -$151,220.00 | |
Cash paid for puchase of land | -$328,090.00 | |
Net Cash Flow From Investing Activites (B) | -$200,120.00 | |
Cash Flow from Financing Activities: | ||
Cash received from sale of common stock ($142,000 + $416,700 - $106,000 - $279,900) | $172,800.00 | |
Cash paid for dividend | -$20,170.00 | |
Net Cash Flow From Financing Activites (C) | $152,630.00 | |
Total Cash flow from all activities (A+B+C) | $39,450.00 | |
Cash at the beginning of the year | $586,230.00 | |
Cash at the end of year | $625,680.00 |
Dec. 31, 20Y3 Dc. 31, 20Y2 Assets 3Cash 4 Accounts receivable (net) 5 Inventories 6 Investments...
The comparative balance sheet of Navaria Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable $425,140.00 $404,540.00 13 Accrued expenses payable 42,020.00 52,750.00 14 Dividends...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,650.00 $586,340.00 4 Accounts receivable (net) 228,170.00 208,030.00 5 Inventories 641,480.00 617,130.00 6 Investments 0.00 240,290.00 7 Land 328,170.00 0.00 8 Equipment 706,070.00 552,300.00 9 Accumulated depreciation-equipment (165,580.00) (147,010.00) 10 Total assets $2,363,960.00 $2,057,080.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,300.00 $404,860.00 13 Accrued expenses payable (operating expenses) 41,850.00...
Statement of Cash Flows-Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $260,120 $240,850 Accounts receivable (net) 94,230 86,500 Inventories 266,000 256,120 Investments 0 99,230 Land 136,440 0 Equipment 293,490 226,440 Accumulated depreciation-equipment (68,710) (61,060) Total assets $981,570 $848,080 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $177,660 $167,070 Accrued expenses payable (operating expenses) 17,670 22,050 Dividends payable 9,820 7,630 Common stock,...
he comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $270,970 $250,900 Accounts receivable (net) 98,160 90,110 Inventories 277,110 266,820 Investments 0 103,360 Land 142,130 0 Equipment 305,730 235,880 Accumulated depreciation—equipment (71,580) (63,610) Total assets $1,022,520 $883,460 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $185,080 $174,040 Accrued expenses payable (operating expenses) 18,410 22,970 Dividends payable 10,230 7,950 Common stock, $10 par 55,220 43,290 Paid-in...
Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets 3 Cash $626,640.00 $585,760.00 Accounts receivable (net) 226,900.00 208,390.00 Inventories 641,350.00 616,130.00 Investments 0.00 239,300.00 Land 328,730.00 0.00 Equipment 705,940.00 Accumulated depreciation-equipment (166,970.00) 553,530.00 (148,000.00) $2,055,110.00 Total assets $2,362,590.00 Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.00 52,750.00 Dividends payable 23,580.00 19,500.00 Common stock, $4...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $244,600 $230,160 Accounts receivable (net) 88,610 82,660 Inventories 250,140 244,740 Investments 0 94,820 Land 128,300 0 Equipment 275,980 216,380 Accumulated depreciation—equipment (64,610) (58,350) Total assets $923,020 $810,410 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $167,070 $159,650 Accrued expenses payable (operating expenses) 16,610 21,070 Dividends payable 9,230 7,290 Common stock,...
The comparative balance sheet of Canace Products Inc. for December 31, 20Y6 and 20Y5, is as follows: 1 Dec. 31, 20Y6 Dec. 31, 20Y5 2 Assets 3 Cash $643,740.00 $678,670.00 4 Accounts receivable (net) 567,590.00 546,500.00 5 Inventories 1,010,270.00 983,300.00 6 Investments 0.00 239,830.00 7 Land 520,160.00 0.00 8 Equipment 879,990.00 680,730.00 9 Accumulated depreciation (244,840.00) (200,100.00) 10 Total assets $3,376,910.00 $2,928,930.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $771,010.00 $748,100.00 13 Accrued expenses payable (operating expenses)...
> New Tab Dec 31, 2016 Dec 31, 2045 Assets 3 Cash 5679,240.00 547,320.00 Accounts receivable (net) 982,470.00 5 Inventories Investments 5645,810.00 566,800.00 1,010,630.00 0.00 519,380.00 879,170.00 (245,160.00) 55,374,630.00 7 Land 240,820.00 0.00 680,900.00 (201,330.00) $2,929,420.00 & Equipment Accumulated depreciation 10 Total assets Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) 13 Accrued expenses payable (operating expenses) 14 Dividends payable 15 Common stock, 52 par 16 Paid-in capital: Excess of issue price over par-common stock $771,990.00 64,240.00 $747,520.00 70,210.00...
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: A. The investments were sold for $175,000 cash. B. Equipment and land were acquired for cash. C. There were no disposals of equipment during the year. D. The common stock was issued for cash. E. There was a $500,000 credit to Retained Earnings for net income. F. There was a $90,000 debit to Retained Earnings for cash dividends declared. Prepare a statement of...
Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec 31, 2093 Dec 31, 2092 Assets Cash $585.190.00 $626,100.00 228,630.00 Accounts receivable (net) 208.060.00 Inventories 641,030.00 617,620.00 Investments 0.00 239.850.00 Land 0.00 528.160.00 705.110.00 Equipment 1166.940.00) Accumulated depreciation-equipment Total assets Liabilities and Stockholders' Equity 553.850.00 (147,700.00) 52.056.850.00 $2.382.190.00 Check My Work Assignment Score: 49.13% TEZOVUZLUUMUUUU $423,690.00 case Labilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) 13 Accrued expenses payable (operating...